[go: up one dir, main page]

FI90870C - Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI90870C
FI90870C FI896251A FI896251A FI90870C FI 90870 C FI90870 C FI 90870C FI 896251 A FI896251 A FI 896251A FI 896251 A FI896251 A FI 896251A FI 90870 C FI90870 C FI 90870C
Authority
FI
Finland
Prior art keywords
compound
pyridin
fluorophenyl
formula
hept
Prior art date
Application number
FI896251A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI896251A0 (fi
FI90870B (fi
Inventor
Yoshihiro Fujikawa
Mikio Suzuki
Hiroshi Iwasaki
Mitsuaki Sakashita
Masaki Kitahara
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of FI896251A0 publication Critical patent/FI896251A0/fi
Publication of FI90870B publication Critical patent/FI90870B/fi
Application granted granted Critical
Publication of FI90870C publication Critical patent/FI90870C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
FI896251A 1988-04-26 1989-12-22 Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi FI90870C (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP10309088 1988-04-26
JP10309088 1988-04-26
JP27143988 1988-10-27
JP27143988 1988-10-27
JP1684689 1989-01-26
JP1684689 1989-01-26
PCT/JP1989/000423 WO1989010365A1 (en) 1988-04-26 1989-04-19 Pyrazolopyridine type mevalonolactones
JP8900423 1989-04-19

Publications (3)

Publication Number Publication Date
FI896251A0 FI896251A0 (fi) 1989-12-22
FI90870B FI90870B (fi) 1993-12-31
FI90870C true FI90870C (fi) 1994-04-11

Family

ID=27281590

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896251A FI90870C (fi) 1988-04-26 1989-12-22 Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi

Country Status (10)

Country Link
EP (1) EP0339358B1 (hu)
JP (1) JP2890448B2 (hu)
KR (1) KR970009222B1 (hu)
AT (1) ATE108450T1 (hu)
DE (1) DE68916685T2 (hu)
DK (1) DK659089D0 (hu)
FI (1) FI90870C (hu)
HU (1) HU203888B (hu)
NO (1) NO173501C (hu)
WO (1) WO1989010365A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3130342B2 (ja) * 1991-10-04 2001-01-31 日産化学工業株式会社 動脈硬化性血管内膜肥厚抑制薬
US6949648B2 (en) 2000-03-27 2005-09-27 Takeda Pharmaceutical Company Limited Condensed pyrazole derivatives, process for producing the same and use thereof
WO2009000832A2 (en) * 2007-06-25 2008-12-31 Boehringer Ingelheim International Gmbh Chemical compounds
AU2008331733A1 (en) 2007-11-02 2009-06-11 Vertex Pharmaceuticals Incorporated [1H- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
GEP201706620B (en) 2012-06-29 2017-02-10 Pfizer NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS
WO2015092592A1 (en) 2013-12-17 2015-06-25 Pfizer Inc. Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
EP3350178B1 (en) 2015-09-14 2021-10-20 Pfizer Inc. Novel imidazo [4,5-c]quinoline and imidazo [4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
DE3582674D1 (de) * 1984-06-22 1991-05-29 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals

Also Published As

Publication number Publication date
JP2890448B2 (ja) 1999-05-17
DK659089A (da) 1989-12-22
EP0339358A1 (en) 1989-11-02
NO173501B (no) 1993-09-13
JPH02275878A (ja) 1990-11-09
EP0339358B1 (en) 1994-07-13
ATE108450T1 (de) 1994-07-15
KR900700480A (ko) 1990-08-13
KR970009222B1 (ko) 1997-06-09
HU892751D0 (en) 1990-03-28
NO895165L (no) 1989-12-21
WO1989010365A1 (en) 1989-11-02
DK659089D0 (da) 1989-12-22
DE68916685D1 (de) 1994-08-18
FI896251A0 (fi) 1989-12-22
NO173501C (no) 1993-12-22
FI90870B (fi) 1993-12-31
HU203888B (en) 1991-10-28
DE68916685T2 (de) 1995-02-09
NO895165D0 (no) 1989-12-21

Similar Documents

Publication Publication Date Title
CA1336714C (en) Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
FI63587B (fi) Foerfarande foer framstaellning av anti-inflammatoriska halogenerade 4-hydroxi-2-alkyl-3-karbamoyl-2h-tieno-1,2-tiazin-1,1-dioxidderivat
HRP950505A2 (en) Cycloalkano-indole- and -azaindole derivatives
US20050272761A1 (en) 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
KR20200100753A (ko) Lpa 길항제로서의 시클로헥실 산 피라졸 아졸
CH675246A5 (hu)
US20040248950A1 (en) Apo ai expression accelerating agent
KR20200100723A (ko) Lpa 길항제로서의 시클로헥실 산 피라졸 아진
US5026698A (en) Thienopyridine type mevalonolactones
KR20210060546A (ko) Lpa 길항제로서의 옥사비시클로 산
EP2139881B1 (en) Quinolines and their therapeutic use
US7208518B2 (en) Substituted furochromene compounds of antiinflammatory action
US5055472A (en) Pyrazolopyrimidine type mevalonolactones
FI90870C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi
JPH072770A (ja) 新規な置換インドール類、その製造法及びそのインドール類を含有する製剤組成物
US5026708A (en) Pyrimidine type mevalonolactones
JP7263659B2 (ja) カルボン酸基を含む窒素含有ベンゾ複素環化合物、その調製方法及び使用
US5024999A (en) Pyrazolopyridine type mevalonolactones useful as pharmaeuticals
FI85473B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat och mellanprodukter.
EP0987253A1 (en) Pyrazolone derivatives
US5362879A (en) 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
US4977161A (en) Isoxazolopyridine type mevalonolactones
JPH0592985A (ja) ＨＭＧ−ＣｏＡリダクターゼインヒビター
Cherkupally et al. Synthesis and antimicrobial study of bis-[thiadiazol-2-yl-tetrahydro-2H-pyrazolo [3, 4-d][1, 3] thiazole] methanes.
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: NISSAN CHEMICAL INDUSTRIES LTD.